Skip to main content
. 2021 Sep 30;12:731048. doi: 10.3389/fimmu.2021.731048

Figure 2.

Figure 2

Construction of risk signature based on the expression of HRLs. (A) The coefficient of 19 HRLs for the construction of risk signature. (B, C) The risk score and survival time of each sample in the TCGA (B) and CGGA (C) datasets. (D) Time-dependent ROC analysis of risk score in predicting 1-, 3-, and 5-year survival. (E, F) The expression of 19 HRLs in each sample from low risk to high risk in the TCGA (E) and CGGA (F) datasets. (G–J) The risk score in different grades (G), IDH status (H), 1p19q status (I), and MGMT status (J) of gliomas in the two datasets. ****p < 0.0001; ns, no significance.